America produces Pfizer and Biontech for safe Covid-19 vaccines, creating a strong immune response in clinical trials in children 5-11 years old.

Pfizer and Biontech today announced the results of clinical trial of Vaccine Covid-19 in children 5-11 years old.

Vaccine Coval-19 nurse was first for Andres Clara, 12 years old, in New York state on May 14.

Common side effects in teenagers and adults are fatigue, headache, muscle pain, chills, fever and nausea, according to US disease control and prevention agencies (CDC).

We look forward to expanding the protection capacity of the vaccine to this younger population, depending on the management agency, in the context of powerful Delta transformations and is significantly threatening to children, Albert Bourla, Monitoring

New data given when many parents are worried to go to the vaccination, in the context of the re-opening school and the Delta transformation continues to rage.

FDA licensed the Pfizer / Biontech Covid-19 vaccine for children 12 years and older, and Johnson & Johnson's vaccine and Johnson for adults.

Bourla last week said that Pfizer could send data about children 5-11 years at the end of this month, and expected to announce the results of vaccine clinical trials in children aged 6 months earliest at the end of October